The BetterBirth program and their global partners hosted this session at HSR 2022 in Bogota, Colombia to share findings from the LIFE Study and discuss how to improve care for the millions of small and sick newborns born each year.
WhatMatters.com highlights how Ariadne implemented objectives and key results (OKRs) to set big goals and measure our impact.
Dr. Robert Green pens a commentary in the Chicago Tribune on genetic testing and how some celebrities have raised awareness by sharing their genetic risks publicly.
Dr. David Levine in the New York Times on the Home Hospital model.
The health care innovation center launches an open-education initiative to empower the public to save lives and reduce suffering. BOSTON, Nov. 16, 2022 – Ariadne Labs, a joint center for health systems innovation at Brigham and Women’s Hospital and the Harvard T.H. Chan School of Public Health, is pleased to announce it has launched a… Continue reading Ariadne Labs Announces Clinton Global Initiative Commitment
BOSTON, MA – October 24, 2022 — Ariadne Labs today announced Ambassador Román Macaya, PhD, MBA, as a new member of its Advisory Board. Formerly Costa Rica’s Ambassador to the United States, Ambassador Macaya will serve as a trusted advisor to Ariadne Labs’ mission to save lives and reduce suffering. “We are thrilled to welcome… Continue reading Ariadne Labs Names Ambassador Román Macaya to Advisory Board
BetterBirth’s Megan Marx Delaney spoke on the Reproductive Health Supplies Coalition’s webinar series on recent findings from the BetterBirth trial on oxytocin use.
Representatives of community members, public sector organizations, and community-based organizations shared their first-hand experiences with inequities in the current system, and their cooperative effort to design an approach of more equitable care.